News und Analysen
Dick Cheney Net Worth: Wealth Behind the Power
With a huge net worth of $150 million, Dick Cheney is among the richest American politicians. He is a Republican who served in the administrations of George H.W. Bush and George W. Bush. He was the
Mauricio Umansky Net Worth: Luxury Real Estate Trailblazer
Mauricio Umansky is a prominent name in the luxury real estate industry. Though he is famous for being the husband to The Real Housewives of Beverly Hills’s cast Kyle Richards, his net worth says
Investors Go into Risk-Off Mode for the Fund-Flows Week
Investors were net purchasers of fund assets (including those of conventional funds and ETFs) for the third week in four, injecting a net $10.8 billion for the LSEG Lipper fund-flows week ended
Apple – Korrektur birgt interessante Investmentchancen
Rund zehn Prozent hat die Aktie von Apple in den zurückliegenden 10 Tagen verloren. Damit wurden über 200 Milliarden US-Dollar ausradiert. Katalysator des Kurssturzes waren die Zahlen für das
Gold Is Getting At An Interesting Level – CPI Early Clues
Yesterday‘s S&P 500 downswing didn‘t last even though the sellers came back strongly before the day was over. Bonds though have recovered, 10y yield is sitting at 4% – the interest rate sensitive
Gov. Signs Largest Property Tax Cut In Texas History: How it Benefits You
Texas Gov. Greg Abbott ceremonially signed the $18 billion property tax relief bill into law on Wednesday. The bill, which is the largest property tax cut in Texas history, will bring massive
UPS Slipping To More Attractive Levels On Weak Outlook
Key Points
- UPS falls on soft results and outlook, but a buying opportunity could be close.
- Internal improvements set the company up for leverage over the long term; however, a rebound could
S&P 500 Bears Repulsed, Briefly
S&P 500 reversed mid session, but it would be premature to call for the end of the correction – odds are that following today‘s rebound, which I saw as likely to stall in the 4,535 area as easy
Online Prices Fall For Eleventh Consecutive Month, Dropping 1.6% In July
- Online prices dropped 1.6% compared with July 2022, and 0.9% from June 2023
- Grocery price increases have now slowed for 10 consecutive months
- Categories including appliances
50% Off And A 6% Dividend… Is Crown Castle REIT Royalty?
Key Points
- Crown Castle is trading 50% below its January 2021 record peak and has a forward dividend yield that has doubled to 6%.
- Unlike most REITs that invest in buildings, Crown Castle
S&P 500 Correction Here
S&P 500 did the compulsory little rebound yesterday – one I didn‘t trust from the get go, yet maxed it out for subscribers enjoying also the Intraday Signals. Stocks had been gradually
Video Game M&A Surges In Q2 2023 With Big-Name Mobile Deals
Quotes from Neil Barbour, associate research analyst at S&P Global Market Intelligence:
“The renewed video game M&A deal activity came as a bit of a surprise as it arrived amid a legal battle
Starbucks Market at a Turning Point: Is a Breakout Imminent?
Key Points
- Starbucks had a mixed Q2 but posted record results and guided for growth.
- Analysts have lowered their price targets for the stock but still see it trending higher by 10%.
S&P 500 Uptrend Questioned
S&P 500 couldn‘t keep the fine rebound as all eyes were on “good that the job market is still OK, but maybe the Fed would stop hiking now” interpretation of weaker than expected non-farm payrolls
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklung
- Wichtige Fortschritte in der Weiterentwicklung der Pipeline durch den Beginn der zulassungsrelevanten Phase-3-Studie mit BNT316/ONC-392 sowie Vorbereitungen für mehrere geplante Studienstarts im
S&P 500 Uptrend Resumption
S&P 500 reversed right on cue yesterday, and the retreat before Apple Inc (NASDAQ:AAPL) earnings was duly bought. Next, it was up to the run up to the non-farm payrolls – stocks froze with fear for
Productivity Surges 3.7% In The Second Quarter
In his podcast addressing the markets today, Louis Navellier offered the following commentary.
Energy Bet Paying Off
My big energy bet is paying off now that we are in the midst of peak
Top 10 Stocks To Watch In August 2023
In summary:
- S&P 500 E-Mini Futures reached a year-to-date high of about $4,600, with potential for new all-time highs if it surpasses resistance at $4,630 and $4,700.
- The $4,500 support
S&P 500 Fails To Take Advantage Of Respite In Rising Yields
S&P 500 couldn‘t take advantage of respite in rising yields after US open as there was no reprieve. No flight to safety to Treasuries to which there‘s no deep enough alternative – yields continued
Stonebranch wird im Gartner® Hype Cycle™ für I&O-Automatisierung 2023 anerkannt
Dieser Bericht enthält Empfehlungen für I&O-Führungskräfte, die Effizienzsteigerungen und Innovationen anstreben, Mitarbeitende weiterbilden und Kosten und Wert optimieren möchten
ALPHARETTA
Do Caterpillar’s Results Hint At A Looming Infrastructure Bubble?
Caterpillar, Inc. (NYSE:CAT) stock is up nearly 8% in early trading after the company blew past revenue and earnings expectations. The question will be whether the report will be enough to move
Jamie Dimon Calls Fitch Downgrade Of U.S. Credit ‘Ridiculous’
Following is the unofficial transcript of a CNBC exclusive interview with JPMorgan Chase & Co (NYSE:JPM) Chairman & CEO Jamie Dimon on CNBC’s “Power Lunch” (M-F, 2PM-3PM ET) today, Wednesday
Gold’s, And Gold Miners’ Fake Rally Was Erased – Just As Expected
What a difference 24h can make, huh? Gold rallied visibly on Monday, only to give it back on Tuesday. Same with miners. What’s next?
Exactly the same thing that was likely before yesterday’s
The Treasury Department May Have Bitten Off More Than It Can Chew
In his podcast addressing the markets today, Louis Navellier offered the following commentary.
Spooky Treasuries
Financial markets were spooked that the Treasury Department now wants to
Zenas BioPharma gibt die Veröffentlichung von Daten zu einer Phase-2-Studie mit Obexelimab, einem Prüfpräparat zur Behandlung der IgG4-assoziierten Erkrankung (IgG4-RD), im Fachjournal „The Lancet Rheumatology“ bekannt
Die Studie ergab, dass Obexelimab bei den meisten Patientinnen und Patienten mit aktiver IgG4-RD zu einer schnellen, deutlichen und anhaltenden klinischen Verbesserung, einschließlich einer